Financials
- Market Capitalization 163.9009 M
- Employee 184
- Founded 2004
- CEO Laura Niklason
- Website www.humacyte.com
- Headquarter Delaware, United States
- FIGI BBG00XPPT7S7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.02
売上高対価格比率
0.8
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 6941 | SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0237 USD | -10.90% | -14.13% | +39.41% | -9.89% | 344.84 M USD | ||
| 7048 | YDESW YD Bio Limited - Warrants | 0.4000 USD | 0.00% | +14.29% | +60.00% | -60.00% | 269.00 M USD | ||
| 7150 | ENGNW enGene Therapeutics Inc. - Warrants | 0.2200 USD | 0.00% | -11.68% | -56.33% | -66.15% | 122.59 M USD | ||
| 7166 | FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.70 USD | -0.11% | +1.30% | -1.01% | +110.11% | 101.51 M USD |